首页|中美药物基因组学教育发展概况

中美药物基因组学教育发展概况

扫码查看
药物基因组学(pharmacogenomics,PGx)是一门基于功能基因组学与分子药理学的科学,近年来迅速发展并逐步应用于临床,中美两国也因此致力于推动PGx教育的发展.本文对中美PGx教育作一综述,阐明发展PGx教育的重要性,并详细介绍PGx教育在高校和临床中的发展现状以及所面临的挑战.此外,本文就两国PGx教育发展提出一些建议并探讨未来的发展趋势.
Development of pharmacogenomics education in China and the Unit-ed States
Pharmacogenomics(PGx)is a science based on functional genomics and molecular phar-macology,which has been rapidly developed and gradually applied to clinical practice in recent years.Therefore,China and the United States are committed to promoting the development of PGx education.This paper reviews PGx education in Chi-na and the United States,clarifies the significance of developing PGx education,and provides a de-tailed introduction to the current development sta-tus and challenges of PGx education in universities and clinical settings.Additionally,this paper makes some recommendations for developing PGx educa-tion and discusses future development trends in both countries.

pharmacogenomicscourse offeringprofessional trainingclinical practiceteaching de-sign

王泉林、孙树森、张伟、曹丹、金一粟

展开 >

中南大学湘雅医院临床药理研究所,长沙 410008,湖南

美国西新英格兰大学药学院,斯普林菲尔德01119,马萨诸塞州

中南大学教师教学发展中心,长沙 410000,湖南

药物基因组学 课程开设 专业培养 临床实践 教学设想

湖南省教育教学改革项目

HNJG-2022-0458

2024

中国临床药理学与治疗学
中国药理学会

中国临床药理学与治疗学

CSTPCD北大核心
影响因子:0.97
ISSN:1009-2501
年,卷(期):2024.29(9)